McKesson facility named Center of Excellence for seventh year in a row
The McKesson Specialty Health Reimbursement, Access & Safety Services Solution Center has been named a Center of Excellence by BenchmarkPortal. Read More »
The McKesson Specialty Health Reimbursement, Access & Safety Services Solution Center has been named a Center of Excellence by BenchmarkPortal. Read More »
The McKesson Corp. has announced that it will use CommonWell to make patient information available to health care providers no matter where the patients receive care. Read More »
Pfizer recently announced it is teaming up with Adaptive Biotechnologies to help advance its growing immuno-oncology pipeline. Read More »
Pfizer Inc. announced last week that its Research and Development investment strategy will be expanded to include companies in the initial phases of scientific advancements. Read More »
Shareholders were offered $182 per share for McKesson Corp. common stocks on Dec. 15 by TRC Capital Corp. Read More »
German drugmaker Merck KGaA and U.S. drug giant Pfizer revealed this week that they are collaborating with Syndax Pharmaceuticals to investigate avelumab as a combination treatment for advanced ovarian cancer. Read More »
German drugmaker Merck KGaA and American-based drug giant Pfizer recently initiated two new clinical trials involving the PD-L1 inhibitor known as avelumab. Read More »
Democrat and Republican Senators criticized pharmaceutical companies Wednesday that have drastically hiked up the prices of life-saving medicines. Read More »
As the landscape of the health care industry is ever-changing, the McKesson Pharmacy Optimization team is shedding light on five trends expected to effect health system pharmacies next year. Read More »
The Center for American Progress (CAP) recently submitted a proposal to improve Medicare by offering transparency in drug costs while reducing costs for consumers. Read More »
In the wake of health plans transitioning from broad networks and straightforward reimbursement approaches to narrow networks and alternative payment methods, McKesson Health Solutions introduced a new pricing tool Tuesday called "Reimbursement Manager 3.0." Read More »
Hospice Pharmacy Solutions of Dallas, a pharmacy benefit management (PBM) service, announced Monday that it has merged with Sacramento-based hospice PBM Outcome Resources. Read More »
U.S.-based drugmaker Pfizer said this week it is tackling the rising costs of prescription medicines head on by expanding its patient assistance program so that more people can gain access to free medicines. Read More »
Dallas-based oncology drug development company Arog Pharmaceuticals, Inc. named Ada Braun senior vice president of clinical development on Monday. Read More »
New Haven Pharmaceuticals said data on the antiplatelet effects of Durlaza will be presented in a poster session during the American Heart Association Scientific Sessions that begin this weekend in Orlando, Florida. Read More »
The 28th annual McKesson Health Solutions Conference (MHSC) kicked off Monday at the Aria Resort and Casino in Las Vegas. More than 300 health care professionals from leading payers and providers will engage in networking, learning and focusing on a better future for health care at the conference that runs through Thursday. Read More »
Xerox issued an update Oct. 13 on the strategic direction of its government health care business, focusing the implementation of its Health Enterprise Medicaid platform in California and Montana.Based on discussions with clients in California and Montana, Xerox said is likely it will not fully complete the implementation of the Health Enterprise Medicaid platform, its next-generation Medicaid Management Information System, in these states. Xerox said it expects to continue to process Medicaid cl Read More »
A recent report by the National Center for Policy Analysis (NCPA) found that drug wholesaler price manipulation, coupled with the relationships large drug companies have with drugstores and pharmacies, is having an adverse effect on competition and causing the prices of generic prescription drugs to rise. Read More »
OncLive added the US Oncology Network this week to its Strategic Alliance Partnership program, which is dedicated to raising awareness of cancer treatment and research. “The US Oncology Network was created with patients in mind,” Michael Seiden, chief medical officer of the US Oncology Network, said. Read More »
Merck KGaA, Darmstadt, Germany and Pfizer on Wednesday announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to avelumab, a treatment for metastatic Merkel cell carcinoma. Read More »